Compare RLAY & GBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RLAY | GBX |
|---|---|---|
| Founded | 2015 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Railroads |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2020 | N/A |
| Metric | RLAY | GBX |
|---|---|---|
| Price | $7.81 | $48.73 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 7 | 2 |
| Target Price | $16.00 | ★ $45.00 |
| AVG Volume (30 Days) | ★ 2.3M | 487.7K |
| Earning Date | 02-25-2026 | 01-08-2026 |
| Dividend Yield | N/A | ★ 2.67% |
| EPS Growth | N/A | ★ 0.79 |
| EPS | N/A | ★ 5.77 |
| Revenue | $8,355,000.00 | ★ $3,070,400,000.00 |
| Revenue This Year | $20.47 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $8.29 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.78 | $37.77 |
| 52 Week High | $9.04 | $71.06 |
| Indicator | RLAY | GBX |
|---|---|---|
| Relative Strength Index (RSI) | 47.13 | 55.17 |
| Support Level | $7.85 | $47.18 |
| Resistance Level | $8.66 | $54.15 |
| Average True Range (ATR) | 0.41 | 1.78 |
| MACD | -0.11 | 0.17 |
| Stochastic Oscillator | 18.41 | 33.76 |
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
Greenbrier Companies Inc supplies equipment and services to international freight transportation markets, designing and marketing freight railcars in North America, Europe, and Brazil through subsidiaries and joint ventures. It provides railcar wheel services, parts, maintenance, and conversion services in North America. The company owns a lease fleet sourced mainly from its manufacturing operations and offers railcar management, regulatory compliance, and leasing services to railroads and owners. It operates two segments: Manufacturing and Leasing & Fleet Management, with the majority of revenue from Manufacturing. The company operates in the U.S. and internationally, with the majority of revenue from the U.S. market.